U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
130921130921Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer PatientsCompletedNo Results AvailableBreast Cancer|Elderlyhttps://ClinicalTrials.gov/show/NCT00849758
130922130922Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNo Results AvailableSystemic Lupus Erythematosus|Systemic SclerosisProcedure: Nonmyeloablative allogeneic stem cell transplanthttps://ClinicalTrials.gov/show/NCT00849745
130923130923A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)CompletedNo Results AvailableHIV-1|HIV InfectionsBiological: V520|Biological: Comparator: V520 (1x10^9 vp/d)|Biological: Comparator: V520 (1x10^10 vp/d)|Biological: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00849732
130924130924Effects of a Combination of IV-PCA With Continuous IV Infusion of MO, Versus IV-PCA MO on Postoperative PainNot yet recruitingNo Results AvailablePost Operative PainDrug: a combination of PCA MO and continuous infusion of MO|Drug: PCA MO onlyhttps://ClinicalTrials.gov/show/NCT00849719
130925130925Effect of Work Load and Sleep Deprivation on Medical Staff's Driving SkillsNot yet recruitingNo Results AvailableSleep DeprivationOther: Study participants will work their regular shifts, and tested after night shifts.No shifts will be added because of the study.https://ClinicalTrials.gov/show/NCT00849706
130926130926A Study in the Treatment of Children and Adolescents With Major Depressive DisorderCompletedHas ResultsMajor Depressive DisorderDrug: Placebo|Drug: fluoxetine|Drug: duloxetine|Drug: duloxetinehttps://ClinicalTrials.gov/show/NCT00849693
130927130927A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)CompletedHas ResultsHIV-1|HIV InfectionsOther: Comparator: Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine|Biological: Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)|Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose)|Biological: Comparator: Placebo to MRKAd5 HIV-1 gag vaccinehttps://ClinicalTrials.gov/show/NCT00849680
130928130928Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First RelapseCompletedNo Results AvailableOvarian CancerDrug: MORAb-003 (farletuzumab)|Drug: MORAb-003 (farletuzumab)|Drug: 0.9% Salinehttps://ClinicalTrials.gov/show/NCT00849667
130929130929Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaCompletedNo Results AvailableB-Cell Lymphoma|B-Cell LeukemiaDrug: PCI-32765https://ClinicalTrials.gov/show/NCT00849654
130930130930Muscle Tissue Oxygenation in Patients With Decompensated Liver CirrhosisNot yet recruitingNo Results AvailableLiver Cirrhosishttps://ClinicalTrials.gov/show/NCT00849641
130931130931Use of Drugs and Constipation in Nursing HomesCompletedNo Results AvailableConstipation, Diarrheahttps://ClinicalTrials.gov/show/NCT00849628
130932130932Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionActive, not recruitingNo Results AvailableGastric Cancer|Adenocarcinoma of the Esophagogastric JunctionDrug: Docetaxel|Drug: 5-Fluorouracil|Drug: Oxaliplatin|Drug: folinic acidhttps://ClinicalTrials.gov/show/NCT00849615
130933130933The Effect of Chloroquine in the Treatment of Patients With DengueActive, not recruitingNo Results AvailableDengueDrug: Placebo|Drug: Chloroquinehttps://ClinicalTrials.gov/show/NCT00849602
130934130934Computerized Screening and Brief Physician Advice to Reduce Teen DrinkingWithdrawnNo Results AvailableAlcohol Abuse|Risk BehaviorBehavioral: Computerized screening and brief physician advice|Behavioral: Computerized SBA with technological extendershttps://ClinicalTrials.gov/show/NCT00849589
130935130935Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.CompletedNo Results AvailableType 2 DiabetesDrug: Regular Human Insulin|Drug: Insulin Lispro|Drug: Insulin VIAjectâ„¢ (75%)|Drug: Insulin VIAjectâ„¢ (90%)https://ClinicalTrials.gov/show/NCT00849576
130936130936Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and OutcomesCompletedNo Results AvailableDiabetes Mellitus, Type 2Other: Standardized Risk Assessmenthttps://ClinicalTrials.gov/show/NCT00849563
130937130937Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol Specific|CancerDrug: capecitabine/oxaliplatin/bevacizumab/RAD001 (XELOX-A-Ev)https://ClinicalTrials.gov/show/NCT00849550
130938130938The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic RetinopathyRecruitingNo Results AvailableDiabetic RetinopathyDrug: Triamcinolonehttps://ClinicalTrials.gov/show/NCT00849537
130939130939Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)TerminatedNo Results AvailableChronic Lymphocytic Leukemia|Small Lymphocytic LymphomaBiological: ISF35https://ClinicalTrials.gov/show/NCT00849524
130940130940Melatonin for Migraine PreventionCompletedNo Results AvailableMigraineDrug: melatoninhttps://ClinicalTrials.gov/show/NCT00849511
130941130941Levetiracetam 750 mg Tablets Under Non-Fasting ConditionsCompletedHas ResultsHealthyDrug: Levetiracetam|Drug: Keppra®https://ClinicalTrials.gov/show/NCT00849485
130942130942Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedHas ResultsNeoplasms, BreastDrug: doxorubicin + cyclophosphamide|Drug: paclitaxel + pazopanib|Procedure: surgery|Drug: pazopanib monotherapyhttps://ClinicalTrials.gov/show/NCT00849472
130943130943Gene Therapy in Treating Women With Metastatic Breast CancerRecruitingNo Results AvailableBreast CancerBiological: adenovirus-mediated human interleukin-12|Other: enzyme-linked immunosorbent assay|Other: fluorescence activated cell sorting|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00849459
130944130944Validity and Reliability of an Activity Monitor in Persons With a Cerebrovascular AccidentCompletedNo Results AvailableCerebrovascular AccidentDevice: Activity monitor (SenseWear Pro armband)https://ClinicalTrials.gov/show/NCT00849446
130945130945Effects of Smoking on Bronchial EpitheliumCompletedNo Results AvailableAsthma|Copdhttps://ClinicalTrials.gov/show/NCT00849433
130946130946Genetic Risk Factors and Acquired Oncogenic Mutations of MelanomaRecruitingNo Results AvailableMelanomahttps://ClinicalTrials.gov/show/NCT00849407
130947130947Evaluation of Protein in the Urine in Patients Receiving BevacizumabCompletedNo Results AvailableColon Cancer|Rectal Cancerhttps://ClinicalTrials.gov/show/NCT00849394
130948130948Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or ThailandCompletedHas ResultsInfections, PapillomavirusBiological: GSK580299, GSK Biological's HPV vaccinehttps://ClinicalTrials.gov/show/NCT00849381
130949130949Azathioprine & Allopurinol in Inflammatory Bowel Disease PatientsCompletedNo Results AvailableInflammatory Bowel DiseaseDrug: Azathioprine / Allopurinolhttps://ClinicalTrials.gov/show/NCT00849368
130950130950Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) RiskRecruitingNo Results AvailableNo Hodgkin B LymphomaDrug: RCOMP-14 + rituximabhttps://ClinicalTrials.gov/show/NCT00849355

* Görseller ve İçerik tekif hakkına sahip olabilir